US 8299087
Compositions and methods for inhibition of the JAK pathway
granted A61KA61K31/506A61K31/5375
Quick answer
US patent 8299087 (Compositions and methods for inhibition of the JAK pathway) held by Rigel Pharmaceuticals, Inc. expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/506, A61K31/5375, A61K31/538, A61K31/5383